ALAB stock rose 3.03% to $320.68 Monday as Astera Labs moved toward Tuesday’s close and second-quarter earnings expectations.
David Coleman is a columnist at the Irish Independent and Sunday Independent. With over 25 years of experience as a clinical psychologist, he specializes in child and teenage development, parenting, and family life, often sharing his insights through his writing, television shows, and radio appearances. He has been featured in various publications, including the Mirror and The Australian Financial Review.















